RIZZI LAURA
- U08, Floor: 2, Room: 2021
Publications
Meanti, R., Bresciani, E., Rizzi, L., Molteni, L., Coco, S., Omeljaniuk, R., et al. (2025). Cannabinoid Receptor 2 (CB2R) as potential target for the pharmacological treatment of neurodegenerative diseases. BIOMÉDECINE & PHARMACOTHÉRAPIE, 186 [10.1016/j.biopha.2025.118044]. Detail
Meanti, R., Rizzi, L., Bresciani, E., Licata, M., Molteni, L., Omeljaniuk, R., et al. (2024). Selected Growth Hormone Secretagogues (GHS) as disease modifiers in an in vitro model of Amyotrophic Lateral Sclerosis: a proof-of-concept study. Intervento presentato a: 9th European Congress of Pharmacology (EPHAR 2024), Atene, Grecia. Detail
Meanti, R., Rizzi, L., Bresciani, E., Licata, M., Molteni, L., Omeljaniuk, R., et al. (2024). Potential application of Growth Hormone Secretagogues (GHS) for Amyotrophic Lateral Sclerosis (ALS) treatment: mechanisms of action and neuroprotective effects characterization in human SH-SY5Y SOD1G93A cells. Intervento presentato a: Innovazione e malattie rare: dalla ricerca preclinica al paziente, Bari, Italia. Detail
Meanti, R., Rizzi, L., Bresciani, E., Licata, M., Sartori, E., Omeljaniuk, R., et al. (2024). Selected Growth Hormone Secretagogues (GHS) as promising therapeutical approach for Amyotrophic Lateral Sclerosis: a proof-of-concept study. Intervento presentato a: 42° Congresso Nazionale SIF. Science today for a better medicine tomorrow, Sorrento, Italia. Detail
Bianchi, V., Rizzi, L., Somaa, F. (2023). The role of nutrition on Parkinson’s disease: a systematic review. NUTRITIONAL NEUROSCIENCE, 26(7), 605-628 [10.1080/1028415X.2022.2073107]. Detail
Research projects
Awards
Awards
- Best poster communication award, Società Italiana di Farmacologia -SIF, 2019
Research and teaching assignments
- Ricercatore universitario a t.d. - Università degli Studi di MILANO-BICOCCA, 2024
- Ricercatore universitario a t.d. - Università degli Studi di MILANO-BICOCCA, 2019 - 2024